Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Webb

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Aesthetic Plastic Surgery|December 13, 2025
When Genes Meet Gels: Computational Immunogenetics of Dermal Fillers and Stratified Risk of Immune and Fibrotic Reactions across Compositions and GenotypesEqram Rahman, Parinitha Rao, Alain Michon, et al.
Emergency Radiology|January 30, 2010
Thoracic CT findings of novel influenza A (H1N1) infection in immunocompromised patientsBrett M Elicker, Brian S Schwartz, Catherine Liu, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 27, 2025
If accessory proteins dissociate, why Don't toxins behave the same? multiscale simulation shows divergent in silico profiles despite an identical core neurotoxinEqram Rahman, Alain Michon, Parinitha Rao, et al.
Blood Pressure|August 23, 2016
Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly TrialChristopher J Bulpitt, Richard Webb, Nigel Beckett, et al.
Journal of Pharmaceutical Sciences|December 23, 2025
Excipient substitution in botulinum toxin type A formulations: Insights from multi-scale in silico modellingEqram Rahman, Alain Michon, Parinitha Rao, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calciumNeenu Singh, Richard Webb, Rachel Adams, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 31, 2025
Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indicationsEqram Rahman, Alain Michon, Parinitha Rao, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 17, 2025
Breaking the 4-hour rule: Multiscale computational modelling redefines post-injection restrictions for botulinum neurotoxin AEqram Rahman, Alain Michon, Parinitha Rao, et al.
Aesthetic Plastic Surgery|July 7, 2026
Computational Trial of Prophylactic Biostimulator Interventions to Mitigate Facial Sagging Associated With GLP-1 Receptor Agonist Induced Weight LossEqram Rahman, Alain Michon, Parinitha Rao, et al.
Cytokine|February 23, 2025
Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors (particularly the rs2228145 variant of the IL-6R gene): A clinical studyKatie Rees, Rebecca Aicheler, Lee Butcher, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Aesthetic Plastic Surgery|December 13, 2025
When Genes Meet Gels: Computational Immunogenetics of Dermal Fillers and Stratified Risk of Immune and Fibrotic Reactions across Compositions and GenotypesEqram Rahman, Parinitha Rao, Alain Michon, et al.
Emergency Radiology|January 30, 2010
Thoracic CT findings of novel influenza A (H1N1) infection in immunocompromised patientsBrett M Elicker, Brian S Schwartz, Catherine Liu, et al.
Toxicon : Official Journal of the International Society on Toxinology|November 27, 2025
If accessory proteins dissociate, why Don't toxins behave the same? multiscale simulation shows divergent in silico profiles despite an identical core neurotoxinEqram Rahman, Alain Michon, Parinitha Rao, et al.
Blood Pressure|August 23, 2016
Antihypertensive treatment decreases arterial stiffness at night but not during the day. Results from the Hypertension in the Very Elderly TrialChristopher J Bulpitt, Richard Webb, Nigel Beckett, et al.
Journal of Pharmaceutical Sciences|December 23, 2025
Excipient substitution in botulinum toxin type A formulations: Insights from multi-scale in silico modellingEqram Rahman, Alain Michon, Parinitha Rao, et al.
Biochemical and Biophysical Research Communications|June 14, 2005
The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calciumNeenu Singh, Richard Webb, Rachel Adams, et al.
Toxicon : Official Journal of the International Society on Toxinology|October 31, 2025
Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indicationsEqram Rahman, Alain Michon, Parinitha Rao, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 17, 2025
Breaking the 4-hour rule: Multiscale computational modelling redefines post-injection restrictions for botulinum neurotoxin AEqram Rahman, Alain Michon, Parinitha Rao, et al.
Aesthetic Plastic Surgery|July 7, 2026
Computational Trial of Prophylactic Biostimulator Interventions to Mitigate Facial Sagging Associated With GLP-1 Receptor Agonist Induced Weight LossEqram Rahman, Alain Michon, Parinitha Rao, et al.
Cytokine|February 23, 2025
Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors (particularly the rs2228145 variant of the IL-6R gene): A clinical studyKatie Rees, Rebecca Aicheler, Lee Butcher, et al.
Pageof 14